BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:UDP-003 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of UDP-003\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06813339-1169@assetmemo.bio
DTSTAMP:20261121T005825Z
DTSTART;VALUE=DATE:20261230
DTEND;VALUE=DATE:20261231
SUMMARY:UDP-003: Phase 1 readout est. (NCT06813339)
DESCRIPTION:UDP-003\, phase 1\, Atherosclerotic Cardiovascular Disease.\nSt
 udy: Placebo-controlled Study of Single and Multiple Ascending Doses of UD
 P-003 in Healthy Human Participants and Followed by an Open-label Patient 
 Cohort\nEstimated primary completion: 30 December 2026. This is a Clinical
 Trials.gov estimate\, not a confirmed readout date\, and it can move.\nDru
 g page: https://assetmemo.bio/drug/udp-003#upcoming-events\nRegistry recor
 d: https://clinicaltrials.gov/study/NCT06813339
URL:https://assetmemo.bio/drug/udp-003#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
